Q250P (p.Gln250Pro) variant of GLA (Alpha-galactosidase A)

Q250P (p.Gln250Pro) in GLA (Alpha-galactosidase A) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic/likely pathogenic in the context of Fabry disease. The available variant effect predictions contribute to a CATVariant prioritization score of 0.80 / 1. The record also includes published literature and structural context.

Q250P (p.Gln250Pro) variant details